Clinical Trial Update: The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy [Phase 1, Phase 2]

View source ↗

Summary

A terminated phase 1/2 clinical trial evaluating the effects of cannabidiol (CBD) on electrical and autonomic cardiac function in children with Lennox-Gastaut S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome
• Lennox-gastaut Syndrome

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Gillette Children's Specialty Healthcare | Conditions: Lennox-Gastaut Syndrome, Dravet Syndrome | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-01-03